Disease Area

payer strategies

Payer strategy in life sciences encompasses the approaches drug manufacturers and healthcare systems use to achieve market access, formulary placement, and reimbursement at sustainable prices. Outcomes-based contracts, managed entry agreements, and indication-specific pricing are increasingly prevalent in high-value therapy segments. Health technology assessment methodologies and their convergence across markets are central to access strategy planning.

      0:00 / 0:00